Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03637595 · ClinicalTrials.gov registry record · NA

Efficacy and Mechanisms of Energy Medicine to Decrease Chronic Knee Pain in Outpatient Settings

A NA study, sponsored by NYU Langone Health.

Terminated
Registry status
NA
Development phase
10
Enrollment target

NCT03637595: Clinical Trial NA study, sponsored by NYU Langone Health.

NCT03637595 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03637595, a NA study, was terminated before completion, sponsored by NYU Langone Health.

TERMINATED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This study will assess the efficacy and mechanisms behind Energy Medicine in reducing chronic knee pain within an outpatient setting. This study will investigate a form of Energy Medicine (EM) performed by a natural solo practitioner, using a standard number of three sessions, which will compare to both positive and negative control groups. The positive control group will receive acupuncture and the negative control group will receive a sham intervention.

Primary Outcome

11 point scale (0-10) asking patient leve of discomfort. A state of no pain is "0" and worst pain is "10"

Interventions

  • PROCEDURE Acupuncture
  • PROCEDURE Enery Medicine Intervention
  • PROCEDURE Sham Energy Medicine

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-06-12
Est. Completion 2019-11-27
Phase NA
NYU Langone Health

1,164 total trials

Why NCT03637595 stopped before completion

NCT03637595 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Acupuncture is the first listed.

NCT03637595 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03637595 about?

NCT03637595 is a clinical study titled "Efficacy and Mechanisms of Energy Medicine to Decrease Chronic Knee Pain in Outpatient Settings". This study will assess the efficacy and mechanisms behind Energy Medicine in reducing chronic knee pain within an outpatient setting. This study will investigate a form of Energy Medicine (EM) performed by a natural solo practitioner, using a standard number of three sessions, which will compare to ...

What is the current status of trial NCT03637595?

This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2019-06-12. Estimated completion is 2019-11-27.

What interventions are being tested in trial NCT03637595?

The interventions under investigation include: Acupuncture (PROCEDURE), Enery Medicine Intervention (PROCEDURE), Sham Energy Medicine (PROCEDURE).

Who is sponsoring clinical trial NCT03637595?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03637595's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03637595, the US trial registry maintained by the National Library of Medicine. NCT03637595 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.